CN1133438C - Prepn. of polyvinylpyrrolidone ointment - Google Patents
Prepn. of polyvinylpyrrolidone ointment Download PDFInfo
- Publication number
- CN1133438C CN1133438C CNB01127705XA CN01127705A CN1133438C CN 1133438 C CN1133438 C CN 1133438C CN B01127705X A CNB01127705X A CN B01127705XA CN 01127705 A CN01127705 A CN 01127705A CN 1133438 C CN1133438 C CN 1133438C
- Authority
- CN
- China
- Prior art keywords
- povidone iodine
- ointment
- water
- add
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a preparation method for povidone iodine ointment. Povidone iodine ointment comprises the following raw materials: 10% of povidone iodine, 0.2 to 0.25% of potassium iodate, 8.1 to 9% of octadecanol, 5.4 to 6% of hexadecanol, 9 to 10% of single stearin, 3 to 3.5% of sodium dodecyl sulfate, 13.5 to 15% of glycerol and 46.25 to 50.8% of purified water. The purified water is added to the povidone iodine to dissolve the povidone iodine. First, povidone iodine is put into an emulsification pot, and is closed and heated to 60 DEG C to 70 DEG C in a water bath; second, the water solution of other components of a water phase heated to constant temperature is taken to be added in the emulsification pot, the water solution and povidone iodine liquid are agitated and uniformly mixed, and are prepared into the water phase; finally, the water phase and a constant oil phase are mixed, agitated and emulsified into ointment. The povidone iodine ointment prepared by the present invention has the characteristics of moderate stickiness, uniformity, fineness, good coating performance, stable long-term storage main medicine content, no delamination, no coarsening, no liquefaction or no deterioration, and is suitable for skin injury, bacterium dermatopathy, fungus dermatopathy and virus dermatopathy.
Description
The present invention relates to the preparation method of a kind of preparation of medicine, particularly a kind of povidone iodine ointment.
Povidone iodine is a kind of Cidex-7 of broad-spectrum high efficacy.Povidone iodine can progressively discharge iodine and bring into play antibacterial action, and its mechanism of action is to make bacterium protein degeneration, death, and is all effective to antibacterial, fungus, virus, is characterized in little to tissue irritation.Its indication is: (1) is used for skin injury, as the prevention and the treatment of burn, scald, cold injury, knife injury, scratch infection; (2) be used for antibacterial, fungus and viral dermatosis, as the treatment of impetigo, furuncle, paronychia and infective ulcer, herpes simplex.At present, its dosage form has solution, suppository, ointment, gel etc.The principal agent povidone iodine of povidone iodine ointment is a kind of strong oxidizer, and volatility is arranged, and the component in mastic is big, accounts for 10%, and the stickiness of aqueous solution is big.Povidone iodine ointment has two difficult problems in process of production, and the one, it is moderate how to prepare stickiness, uniform and smooth, coating is good, stores not stratifiedly for a long time, and not alligatoring is not liquefied, stay-in-grade ointment; The 2nd, how to keep the stable content of principal agent in the ointment, in keeping life, quality meets the requirements.
China's application number 93111431 discloses a kind of povidone iodine ointment, its component and content are povidone iodine 2%, stearic acid 10～15%, higher fatty acids 6～10%, petrolatum 0～3.5%, sodium laurylsulfate 1～2%, potassium iodate 0.3～0.6%, glycerol 0～12%, liquid macrogol 30～35%, distilled water 25～35%, in the process for preparation with water, after various compositions are distinguished mixings in the oil phase, two-phase is still mixed under temperature conditions more than 90 ℃, when treating that temperature is reduced to 40 ℃, just gradation evenly adds povidone iodine lentamente, makes a kind of flavous oil-in-water type emulsifiable paste.The problem that this ointment exists is: do not meet " Chinese pharmacopoeia requirement.No matter be " in 1995 version of Chinese pharmacopoeia, still the povidone iodine ointment that records of existing 2 years versions, it is the brownish red ointment of emulsion-type substrate that its character all requires, specification is for containing povidone iodine 10%, contain povidone iodine and be calculated as 0.85～1.15% (g/g) by available iodine, it then is golden yellow, and specification contains povidone iodine and is calculated as 0.18～0.24% (g/g) by available iodine for containing povidone iodine 2%.
It is moderate that the purpose of invention just provides a kind of stickiness, uniform and smooth, and coating is good, stores the preparation method of the stable sumptuous ointment of polyvidone of drug content for a long time.
Povidone iodine ointment of the present invention is by following raw material: povidone iodine 10%, potassium iodate 0.2～0.25%, octadecanol 8.1～9%, hexadecanol 5.4～6%, glyceryl monostearate 9～10%, sodium lauryl sulphate 3～3.5%, glycerol 13.5～15% and purified water 46.25～50.8%, make through following method: (1) is got octadecanol, hexadecanol, glyceryl monostearate and is placed container, heating in water bath, make it fusion, temperature keeps 60 ℃～70 ℃; (2) get sodium lauryl sulphate and purified water 9～10.5% places container, heating, stir and make it dissolving, add glycerol and stir, temperature keeps 60 ℃～70 ℃; (3) get potassium iodate and add purified water 4～5%, after the heating for dissolving, be incorporated in (2) liquid; (4) get povidone iodine and add remaining purified water, dissolving is put in the emulsifying pot, and water-bath is airtight to be heated to 60 ℃～70 ℃; (5) get (2) liquid and be incorporated in the emulsifying pot, then, add the stirring of (4) liquid, mixing; (6) get (1) liquid and add in the emulsifying pot, then, add (5) liquid and mix, the limit edged is stirred to colostrum, and homogenizing outgases into cream.
The present invention selects the formulation and technology of reasonable science according to the character of povidone iodine and the prescription of this ointment, produces high-quality and efficient product.
(1) selects the potassium iodate used as stabilizers, guarantee the stable content of ointment principal agent povidone iodine.Povidone iodine is a kind of strong oxidizer, easily is reduced and causes content and descend, and principal agent is reduced the external appearance characteristic that content descends and is its colour changed into yellow, shoals, and internal characteristics is that iodide ion concentration raises.The present invention's potassium iodate used as stabilizers, effect is better, because potassium iodate is a kind of strong oxidizer, under acid condition, its electrode potential is bigger than the electrode potential of iodine, that is to say, the oxidisability of potassium iodate is stronger than iodine.According to the redox reaction theory, the endogenous cause of ill of decision redox reaction generation direction is the size of electrode potential, promptly be by stronger oxidant and stronger Reducing agent interaction, be converted into more weak Reducing agent and oxidant, so potassium iodate can play function of stabilizer.In prescription, the consumption of potassium iodate should be controlled at 0.2%～0.25% and be advisable, as too high, because of the free-iodine excessive concentration of separating out volatile.Owing to adopted suitable stabilizers, the ointment steady quality that the present invention prepared sees Table 1.Table 1 povidone iodine ointment stability test is test basis as a result: two test types of 2 years versions of Chinese Pharmacopoeia: accelerated test testing equipment: JC303S3A type digital display water isolation type electro-heating standing-temperature cultivator experimental condition: 30 ℃ ± 2 ℃ of temperature; Relative humidity 60% ± 5% test period: measure the centrifugal iodide ion of measurement result time character (%) assay (%) from November 4,5 days to 2000 May in 2000
The brownish red ointment of the 0th month 2000.5.5 emulsion-type substrate does not have layering 0.21 1.12
January, the brownish red ointment of 2000.6.4 emulsion-type substrate did not have layering 0.21 1.11
February, the brownish red ointment of 2000.7.4 emulsion-type substrate did not have layering 0.22 1.09
March, the brownish red ointment of 2000.8.4 emulsion-type substrate did not have layering 0.22 1.08
June, the brownish red ointment of 2000.11.4 emulsion-type substrate did not have layering 0.22 1.08
Conclusion: this product carries out stability test according to 2 years two ones of versions of Chinese Pharmacopoeia and the content detection quality is up to specification.
Note: centrifugal is 3000r/min, and centrifugal 30min observes ointment and has or not layering.
(2) adopt the method for suitable adding principal agent, the preparation povidone iodine ointment.The principal agent povidone iodine has volatility, and aqueous solution has certain vicidity, and the large percentage in ointment accounts for 10%.In preparation ointment process, how adding principal agent is a stubborn problem, routinely, if be made into colostrum earlier, adds the principal agent aqueous solution again, and layering appears in the ointment that then is made into; If the principal agent powder is added Ruzhong just, then be difficult for mixing, form agglomerate; If other composition of principal agent and water is heated together, then Jia Re overlong time causes povidone iodine volatilization loss.Obviously, it is all infeasible to adopt above-mentioned all method adding principal agent povidone iodine to prepare ointment.The applicant is through exploratory development, 75 ℃ of in confined of and 10% povidone iodine aqueous solution is heating in water bath to conditions, and its content only descends 0.02% in the 15min.In view of the above, the method that the applicant adds principal agent is:get povidone iodine and add the purified water dissolving, put in the emulsifying pot, 60 ℃～70 ℃ of water-bath is airtight to be heated to, get then and be heated in other composition aqueous solution adding emulsifying pot of isothermal water, with the povidone iodine stirring and evenly mixing, be made into water altogether, mix, stir, be emulsified into cream with isothermal oil phase again.The advantage of this method is:(1) can make principal agent disperse equably because principal agent elder generation wiring solution-forming mixes with other composition of water again, has solved the difficult problem that adds of principal agent; (2) because the time of heating is short, and temperature is not high, and heats under closed environment, principal agent is not volatile.The ointment stable content that adopts the present invention to prepare out, the conformance with standard requirement.Through making recovery test, the response rate is 102.19%, and the coefficient of variation is 0.68%, shows the favorable reproducibility of technology, PVP-I recovery test (%) (%) (%) 1 1.11 1.13 101.802 1.09 1.12 102.753 1.11 1.12 100.90 108.82 0.684 1.10 1.13 102.735 1.10 1.11 100.91 of average RSD number (by available iodine g) (by available iodine g) of the order PVP-I addition amount of the recording rate of recovery as a result in the results are shown in Table 2. table 2 povidone iodine ointments
(3) select suitable substrate for use, guarantee the suitable stickiness of povidone iodine ointment.The present invention selects high fatty alcohol to make the ointment oil phase, and the ratio of octadecanol and hexadecanol formula ratio can obtain stickiness preferably.Select nonionic surfactant glyceryl monostearate and anionic surfactant so lauryl sulfate to make compound emulsifying agent, the HLB value is 14.70, the HLB value (13～16) required with octadecanol and hexadecanol matches, and the former also has plasticization, and the latter has the bacteriostasis that strengthens oxidant.By the ointment of this formulation, through centrifugal (3000r/min, centrifugal 30min) no layering, the mastic exquisiteness, viscosity is moderate, and coating is good.Get 3 batches of prepared ointment of the present invention, measure dynamic viscosity according to two methods of Chinese Pharmacopoeia version in 2000 respectively, adopt NDJ-1 type Rotary Viscosimeter, with No. 4 rotors, rotating speed is that per minute 6 changes, and the result shows that its viscosity is suitable, the results are shown in Table 3.Table 3 povidone iodine ointment viscosity test result
Lot number dynamic viscosity (PaS)
000501 42
000502 40
000503 43
Conclusion: three batch samples of this product are carried out the viscosity test under by two relevant items of Chinese Pharmacopoeia version in 2000, its stickiness is suitable.
It is moderate that the povidone iodine ointment of the present invention's preparation has stickiness, uniform and smooth, and coating is good, and it is stable to store drug content for a long time, and not stratified, not alligatoring is not liquefied, and the stay-in-grade characteristics are suitable for skin injury, antibacterial, fungus and viral dermatosis.
Below in conjunction with accompanying drawing, the invention will be further described.
Fig. 1 is a process chart of the present invention.
The present invention prepares according to following method: take by weighing octadecanol 0.85Kg, hexadecanol 0.54Kg, glyceryl monostearate 1Kg places the oil phase pot, heating in water bath makes it fusion, and temperature keeps 70 ℃; The purified water that takes by weighing sodium lauryl sulphate 0.3Kg and 0.9Kg places the water pot, and heating, stirring make it dissolving, adds glycerol 1.4Kg and stirs, and temperature keeps 70 ℃; Get potassium iodate 0.025Kg and add the 0.04Kg purified water, after the heating for dissolving, be incorporated in the liquid; Get povidone iodine 1Kg and add the 3.945Kg purified water, dissolving is put in the emulsifying pot, and water-bath is airtight to be heated to 70 ℃; The mixed liquor of getting sodium lauryl sulphate is incorporated in the emulsifying pot, with povidone iodine stirring, mixing; Get the octadecanol mixed liquor and be incorporated in the emulsifying pot, the limit edged is stirred to colostrum, homogenizing, and the degassing becomes cream, makes povidone iodine ointment 10Kg.
3 batches of povidone iodine ointments that the present invention is prepared, through Guangdong Provincial Medicines Checkout station's check, character, discriminating, inspection, assay are all up to specification, see Appendix.
Claims (2)
1. povidone iodine ointment, it is characterized in that by following raw material: povidone iodine 10%, potassium iodate 0.2～0.25%, octadecanol 8.1～9%, hexadecanol 5.4～6%, glyceryl monostearate 9～10%, sodium lauryl sulphate 3～3.5%, glycerol 13.5～15% and purified water 46.25～50.8%, make through following method:
(1) get octadecanol, hexadecanol, glyceryl monostearate and place container, heating in water bath makes it fusion, and temperature keeps 60 ℃～70 ℃;
(2) get sodium lauryl sulphate and purified water 9～10.5% places container, heating, stir and make it dissolving, add glycerol and stir, temperature keeps 60 ℃～70 ℃;
(3) get potassium iodate and add purified water 4～5%, after the heating for dissolving, be incorporated in (2) liquid;
(4) get povidone iodine and add remaining purified water, dissolving is put in the emulsifying pot, and water-bath is airtight to be heated to 60 ℃～70 ℃;
(5) get (2) liquid and be incorporated in the emulsifying pot, then, add the stirring of (4) liquid, mixing;
(6) get (1) liquid and add in the emulsifying pot, then, add (5) liquid and mix, the limit edged is stirred to colostrum, and homogenizing outgases into cream.
2. according to the preparation method of the described povidone iodine ointment of claim 1, it is characterized in that:
(1) get octadecanol, hexadecanol, glyceryl monostearate and place container, heating in water bath makes it fusion, and temperature keeps 60 ℃～70 ℃;
(2) get sodium lauryl sulphate and purified water 9～10.5% places container, heating, stir and make it dissolving, add glycerol and stir, temperature keeps 60 ℃～70 ℃;
(3) get potassium iodate and add purified water 4～5%, after the heating for dissolving, be incorporated in (2) liquid;
(4) get povidone iodine and add remaining purified water, dissolving is put in the emulsifying pot, and water-bath is airtight to be heated to 60 ℃～70 ℃;
(5) get (2) liquid and be incorporated in the emulsifying pot, then, add the stirring of (4) liquid, mixing;
(6) get (1) liquid and add in the emulsifying pot, then, add (5) liquid and mix, the limit edged is stirred to colostrum, and homogenizing outgases into cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01127705XA CN1133438C (en) | 2001-08-04 | 2001-08-04 | Prepn. of polyvinylpyrrolidone ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01127705XA CN1133438C (en) | 2001-08-04 | 2001-08-04 | Prepn. of polyvinylpyrrolidone ointment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1336177A CN1336177A (en) | 2002-02-20 |
| CN1133438C true CN1133438C (en) | 2004-01-07 |
Family
ID=4667627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB01127705XA Expired - Fee Related CN1133438C (en) | 2001-08-04 | 2001-08-04 | Prepn. of polyvinylpyrrolidone ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1133438C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688769B (en) * | 2015-04-01 | 2017-11-10 | 山东司邦得制药有限公司 | Compound montmorillonite povidone iodine ointment and its preparation method and application |
| CN114209646B (en) * | 2021-12-29 | 2024-01-19 | 艾威药业(珠海)有限公司 | Povidone iodine temperature-sensitive gel preparation |
-
2001
- 2001-08-04 CN CNB01127705XA patent/CN1133438C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1336177A (en) | 2002-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011210043B2 (en) | Liquid-crystal emulsion oil in water type and a preparation method of the liquid-crystal emulsion | |
| CN1133438C (en) | Prepn. of polyvinylpyrrolidone ointment | |
| CN101485625B (en) | Amoluofen emulsifiable paste | |
| EP0058959B1 (en) | Method for preparing low-turbidity standard or reference sera | |
| CN109971206A (en) | A kind of hematoxylin dye liquor and preparation method thereof | |
| CN102885852B (en) | Povidone iodine ointment and preparation method thereof | |
| CN105997989A (en) | Urea and vitamin E cream for treating hand and foot rahagades and rahagades caused by keratotic tinea hand or pedis | |
| DE102007007307A1 (en) | Flowable gelatin composition | |
| CN115227641A (en) | Miconazole nitrate emulsifiable paste and preparation method thereof | |
| CN105012237B (en) | Fluticasone furoate nasal spray and preparation method thereof | |
| CN1181820C (en) | Process for preparing miconazole nitrate ointment | |
| CN105560167A (en) | Universal O / W type emulsion type matrix and preparation technology thereof | |
| JPH0278613A (en) | Soft capsule containing essential oil | |
| EP1487496B1 (en) | Test system for evaluating the compatibility of biologically active substances with copolymers | |
| CN112006923B (en) | High internal phase emulsion stabilized by low-content surfactant and preparation method thereof | |
| CN105106106B (en) | A kind of preparation method of Vaccarin ointment | |
| CN108158992B (en) | Emulsifiable paste preparation containing alclometasone dipropionate | |
| EP2866592B1 (en) | Method for producing a film formulation for an edible film, and the use thereof | |
| CN107115306B (en) | A kind of pharmaceutical composition and preparation method thereof containing Pitavastatin Calcium | |
| CN107281094B (en) | A kind of timolol maleate Pharmaceutical composition and preparation method thereof | |
| CN105853352B (en) | A kind of suspension composition and preparation method thereof containing pranoprofen | |
| CN101467960A (en) | Terbinafine hydrochloride emulsifiable paste and preparation method thereof | |
| CN109627667A (en) | A kind of SBS asphalt modifier, preparation method and application | |
| CN108186554A (en) | A kind of desonide cream Pharmaceutical composition and preparation method thereof | |
| KR100302673B1 (en) | Gibberrelic acid paste manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: GUANGDONG KELUN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: GUANGDONG QINGFA PHARMACEUTICAL INDUSTRY CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 514031, on the west side of Ring Road, Meizhou, Guangdong Patentee after: GUANGDONG KELUN PHARMACEUTICAL CO., LTD. Address before: 514031, on the west side of Ring Road, Meizhou, Guangdong Patentee before: Guangdong Qingfa Pharmaceutical Industry Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040107 Termination date: 20190804 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |